Elaine McWhirter

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

Suzanne Richter, Philippe L. Bédard, Eric Xueyu Chen et al. · Investigational New Drugs · 2013 · 80 citations · Full text

A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium

Srikala S. Sridhar, Eric Winquist, Andrea Eisen et al. · Investigational New Drugs · 2010 · 77 citations

Urology, Phase Ii Trial, Genitourinary Cancer +6

Phase II trial of vorinostat in advanced melanoma

Naomi B. Haas, Ian Quirt, Sébastien J. Hotte et al. · Investigational New Drugs · 2014 · 67 citations

Medicine, Melanoma, Oncology +3

A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium

Helen Mackay, H. Au, Elaine McWhirter et al. · Investigational New Drugs · 2011 · 45 citations

Esophageal Cancer, Phase Ii Trial, Gastro Esophageal Junction +8